Utilizing molecules that specifically target the cancer cells, therapeutic radioactive lethal dose can be delivered to specific tumor cells with minimizing damage to the surrounding tissues. The tumors that are impossible to be removed by conventional surgical procedures can be successfully targeted via Radioligand therapy. The damage to the surrounding tissues by conventional chemotherapy can be reduced significantly.
Glioma tumor forms when glial cells grow out of control. Glial cells support nerves and help your central nervous system. Gliomas usually grow in the brain but can also form in the spinal cord. Our proprietary technology binds to the glioma cells directly and results in cancerous cell apoptosis.
When HER2 (human epidermal growth factor receptor 2) levels is higher than normal in breast it is called HER2 positive. We have designed specific molecules that can target the breast cancer cells and disrupt the tumor growth.
Our dedicated team of researchers are using the latest inventions and technologies to bring the future to the patient suffering from cancer. We are striving to eliminate cancer.
Radioligand Therapy is one of the most Promising Technologies for treatment of cancer
Chemotherapy damages all the tissues, while Radioligand therapy targets the canceer cells and avoids other tissues and hence minimizing the side effect.
It is not possible to perform surgery in cancers such as Glioma without endangering the health or the safety of the patients. Radioligand therapy is one of the best hopes for those patients that surgery or chemotherapy are not suitable options.
Targeted radioligand therapy can enhance the effectiveness of immune checkpoint inhibition by improving priming of an immune response or by resetting the immunosuppressive tumor microenvironment to enhance anti-tumor response